Curt Anastasio

October 16, 2026

Goldman Sachs Downgrades Par Pacific to Neutral, Raises Price Target. Goldman Sachs moved Par Pacific Holdings to a Neutral rating from a higher stance, while simultaneously raising its price target to $94. This action places the firm's view in line with the broader analyst consensus, which currently averages $93.29 across seven firms. The stock is trading within a wide 52-week range, with the new target sitting near the upper end of that recent price history.

September 25, 2026

CLB Falls 35% Over Six Months, Analysts Discuss Outlook. CLB has dropped about 35% over the last six months, according to a Yahoo article. Analysts are reviewing the stock’s performance and its target price, which averages $15.00 with a range from $11.00 to $21.00. The share price is currently near its 52‑week low of $9.79 and close to a support level of $12.32. The recent decline may prompt investors to reassess the company’s valuation.

October 12, 2026

Chemours Q2 Earnings Call and UBS Price Target Cut. Chemours released its Q2 2026 earnings call transcript, providing details on its financial performance. UBS kept a neutral stance but lowered its price target to $16, reflecting a more cautious view of the company's outlook. The new target sits below the current average analyst target of $18.22 and near the support level of $15.07, indicating a potential short‑term pressure on the stock.